|
2024
|
Invention
|
Combinations of fasn inhibitors and glp-1 agonists for liver diseases. Combinations of fatty acid... |
|
|
Invention
|
Combination therapies of fasn inhibitors with thyroid hormone receptor agonists.
Therapeutic com... |
|
|
Invention
|
Combination therapies of fasn inhibitors with thyroid hormone receptor agonists. Therapeutic comb... |
|
2023
|
Invention
|
Heterocyclic modulators of lipid synthesis.
Compounds that are fatty acid synthesis modulators a... |
|
2022
|
Invention
|
Methods for prediction of treatment response in non-alcoholic fatty liver disease.
The present d... |
|
|
Invention
|
Methods for prediction of treatment response in non-alcoholic fatty liver disease. The present di... |
|
2021
|
P/S
|
Pharmaceutical and biological preparations for the treatment of cancer; Pharmaceutical and biolog... |
|
2020
|
Invention
|
Heterocyclic modulators of lipid synthesis. Compounds that are fatty acid synthesis modulators ar... |
|
2018
|
Invention
|
Heterocyclic modulators of lipid synthesis. Heterocyclic modulators of lipid synthesis are provid... |
|
2015
|
Invention
|
Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer. Compounds that a... |
|
|
Invention
|
Heterocyclic modulators of lipid synthesis for use against cancer and viral infections. Heterocyc... |
|
2014
|
Invention
|
Heterocyclic modulators of lipid synthesis and combinations thereof. Heterocyclic modulators of l... |
|
|
Invention
|
A combination of heterocyclic modulators of lipid synthesis and chemotherapeutic drugs in treatme... |
